⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

Official Title: IMPACT: Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

Study ID: NCT03570619

Interventions

Nivolumab
Ipilimumab

Study Description

Brief Summary: This study will attempt to determine the efficacy of checkpoint inhibitor immunotherapy with nivolumab and ipilimumab combination therapy followed by nivolumab monotherapy in patients with metastatic prostate cancer and other tumor solid tumor histologies harboring loss of CDK12 function as well as monotherapy nivolumab treatment in patient with metastatic prostate cancer harboring loss of CDK12 function.

Detailed Description: This study investigates the efficacy of checkpoint inhibitor immunotherapy in patients with metastatic cancer with CDK12 mutations. The study includes three cohorts: Cohort A consists of metastatic prostate cancer patients being treated with combination nivolumab and ipilimumab treatment followed by monotherapy nivolumab treatment. Cohort B consists of other solid tumor patients being treated with combination nivolumab and ipilimumab treatment followed by monotherapy nivolumab treatment. As of an amendment approved 03FEB2021 a third cohort was added, Cohort C, which consists of metastatic prostate cancer patients being treated with monotherapy nivolumab treatment. As of an amendment approved 21JUN2020 the maximum duration of treatment, as well as the anticipated timing for some of the studies outcome measures, were updated from 52 weeks to 104 weeks.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of California San Diego, Moores Cancer Center, San Diego, California, United States

University of California San Francisco/Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

H. Lee. Moffitt Cancer Center & Research Institute, Inc., Tampa, Florida, United States

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Karmanos Cancer Institute, Detroit, Michigan, United States

Siteman Cancer Center at Washington University, Saint Louis, Missouri, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Contact Details

Name: Ajjai Alva, MD

Affiliation: Rogel Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: